The Implicit of Psychobiotics: Exploring the Connection Between Gut Health and Mental Wellness

Psychobiotics, a class of probiotics and prebiotics that influence the microbiota–gut–brain axis (MGBA), have emerged as a promising area of research in understanding the relationship between gut health and mental wellness. Recent studies highlight that the gut microbiome plays a crucial role in regulating neurological and psychological functions through neural, endocrine, immune, and metabolic pathways. The gut produces a significant proportion of key neurotransmitters such as serotonin and dopamine, and imbalances in gut microbial composition have been associated with mental health disorders including depression, anxiety, and cognitive decline. Psychobiotics exert their effects through multiple mechanisms, including the production of neurotransmitters such as GABA, serotonin, and dopamine; reduction of systemic inflammation; regulation of the hypothalamic–pituitary–adrenal (HPA) axis to manage stress responses; and epigenetic modulation through short-chain fatty acids that promote neuroplasticity. Evidence from animal models and human clinical trials demonstrates that specific probiotic strains, such as Lactobacillus and Bifidobacterium, may reduce psychological distress, improve mood, lower cortisol levels, and enhance cognitive functions. Alterations in the gut microbiome have also been observed in individuals with major depressive disorder (MDD), suggesting a potential therapeutic role for psychobiotics in mental health management. Emerging research is exploring novel microbial strains and personalized psychobiotic therapies enabled by advancements in genomic technologies. However, limitations remain, including small sample sizes, methodological inconsistencies, uncertain long-term effects, and potential risks for immunocompromised individuals. Despite these challenges, psychobiotics represent a promising adjunctive approach in the prevention and management of mental health disorders by targeting the gut–brain connection.

Authors

Institutions

Publication Details

Published
2026-03-23
DOI
https://doi.org/10.25259/gjgmc_3_2026
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Implicit of Psychobiotics: Exploring the Connection Between Gut Health and Mental Wellness

Shiny Deborah Rani Kankipati
Gut microbiota and health
article

The Implicit of Psychobiotics: Exploring the Connection Between Gut Health and Mental Wellness

Shiny Deborah Rani Kankipati
article en

Abstract

Psychobiotics, a class of probiotics and prebiotics that influence the microbiota–gut–brain axis (MGBA), have emerged as a promising area of research in understanding the relationship between gut health and mental wellness. Recent studies highlight that the gut microbiome plays a crucial role in regulating neurological and psychological functions through neural, endocrine, immune, and metabolic pathways. The gut produces a significant proportion of key neurotransmitters such as serotonin and dopamine, and imbalances in gut microbial composition have been associated with mental health disorders including depression, anxiety, and cognitive decline. Psychobiotics exert their effects through multiple mechanisms, including the production of neurotransmitters such as GABA, serotonin, and dopamine; reduction of systemic inflammation; regulation of the hypothalamic–pituitary–adrenal (HPA) axis to manage stress responses; and epigenetic modulation through short-chain fatty acids that promote neuroplasticity. Evidence from animal models and human clinical trials demonstrates that specific probiotic strains, such as Lactobacillus and Bifidobacterium, may reduce psychological distress, improve mood, lower cortisol levels, and enhance cognitive functions. Alterations in the gut microbiome have also been observed in individuals with major depressive disorder (MDD), suggesting a potential therapeutic role for psychobiotics in mental health management. Emerging research is exploring novel microbial strains and personalized psychobiotic therapies enabled by advancements in genomic technologies. However, limitations remain, including small sample sizes, methodological inconsistencies, uncertain long-term effects, and potential risks for immunocompromised individuals. Despite these challenges, psychobiotics represent a promising adjunctive approach in the prevention and management of mental health disorders by targeting the gut–brain connection.

Vol. 1
Shri Ramswaroop Memorial University (IN)
Good health and well-being
Openalex Percentile: Top 13%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.